Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VINCRISTINE vs VISIPAQUE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VINCRISTINE vs VISIPAQUE: Safety Overview

Metric VINCRISTINE VISIPAQUE
Total FAERS Reports 72,554 136
Deaths Reported 14,548 3
Death Rate 20.1% 2.2%
Hospitalizations 26,911 40
Average Patient Age 41.6 yrs 58.0 yrs
% Female Patients 43.7% N/A
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Hospira, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A